Christopher James Sampson : Citation Profile


Are you Christopher James Sampson?

Office of Health Economics

2

H index

0

i10 index

5

Citations

RESEARCH PRODUCTION:

3

Articles

7

Papers

RESEARCH ACTIVITY:

   6 years (2013 - 2019). See details.
   Cites by year: 0
   Journals where Christopher James Sampson has often published
   Relations with other researchers
   Recent citing documents: 4.    Total self citations: 0 (0 %)

EXPERT IN:

   Health
   Publicly Provided Goods
   Welfare Economics

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/psa1048
   Updated: 2020-01-18    RAS profile: 2019-11-25    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Lorgelly, Paula (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Christopher James Sampson.

Is cited by:

Neri, Margherita (1)

Garau, Martina (1)

Cites to:

Brazier, John (4)

Danzon, Patricia (2)

Newhouse, Joseph (2)

Cubi-Molla, Patricia (1)

Devlin, Nancy (1)

Nelson, Richard (1)

Yin, Wesley (1)

Tsuchiya, Aki (1)

Towse, Adrian (1)

Zhang, Jie (1)

Vogt, William (1)

Main data


Where Christopher James Sampson has published?


Working Papers Series with more than one paper published# docs
MPRA Paper / University Library of Munich, Germany3
Consulting Reports / Office of Health Economics2

Recent works citing Christopher James Sampson (2019 and 2018)


YearTitle of citing document
2019Competition between on-patent medicines in Europe. (2019). Wilsdon, Tim ; Roediger, Alexander ; Azais, Boris ; Pendleton, Kathy ; Haderi, Artes. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:7:p:652-660.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward. (2018). Neri, Margherita ; Garau, Martina ; Towse, A. In: Briefings. RePEc:ohe:briefg:002084.

Full description at Econpapers || Download paper

2019Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States. (2019). Basu, Anirban ; Walton, Surrey M ; Carlson, Josh J ; Ollendorf, Daniel A ; Whittington, Melanie D ; Veenstra, David ; Touchette, Daniel R ; Pearson, Steven D ; McQueen, Brett R ; Campbell, Jonathan D ; Chapman, Richard H. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00832-2.

Full description at Econpapers || Download 2019

Can You Repeat That? Exploring the Definition of a Successful Model Replication in Health Economics. (2019). Sach, Tracey ; Turner, David ; McManus, Emma. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00836-y.

Full description at Econpapers || Download paper

Works by Christopher James Sampson:


YearTitleTypeCited
2019How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy In: Briefings.
[Full Text][Citation analysis]
paper0
2018Barriers to Uptake of Minimal Access Surgery in the United Kingdom In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2018The Impact of New Medicines in the NHS: 70 Years of Innovation In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2018R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C In: Research Papers.
[Full Text][Citation analysis]
paper2
2013Cost implications of treatment non-completion in a forensic personality disorder service In: MPRA Paper.
[Full Text][Citation analysis]
paper0
2013Happy and healthy: a joint model of health and life satisfaction In: MPRA Paper.
[Full Text][Citation analysis]
paper0
2013The relationship between individual risk and cost-effectiveness in screening interventions In: MPRA Paper.
[Full Text][Citation analysis]
paper0
2013Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2019Transparency in Decision Modelling: What, Why, Who and How? In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2017Model Registration: A Call to Action In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
article2

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated January, 6 2020. Contact: CitEc Team